In this article, well explore how retatrutide and related GLP-1 medications affect lipids, with a special focus on the glucagon receptor pathway that may explain their LDL-lowering effect
The onset of appetite suppression varies, but most researchers notice meaningful changes within the first two weeks of reaching therapeutic doses
Monthly persistency erosion is steeper in obesity: Obesity GLP-1s drop to 32% persistence over 13 months, compared to 41% for diabetes
Can I get GLP-1s for free
Abbreviations T2D: Type 2 diabetes SA: Sleep apnea GLP-1RAs: Glucagon-like peptide-1 receptor agonists LDSC: Linkage disequilibrium score regression MR: Mendelian Randomization IVW: Inverse-variance weighted GWAS: Genome-wide association study eQTL: Expression quantitative trait loci SNP: Single nucleotide polymorphism HbA1c: Glycated hemoglobin A1c OSA: Obstructive sleep apnea CSA: Central sleep apnea AHI: Apneahypopnea index NAFLD: Non-alcoholic fatty liver disease RCT: Randomized controlled trials IV: Instrumental variables References Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al
Take our quick quiz today
